Polymorphisms in Phase I and Phase II genes and breast cancer risk and relations to persistent organic pollutant exposure: a case–control study in Inuit women

Perfluorinated compounds affect the function of sex hormone receptors

(2013) Lisbeth Stigaard Kjeldsen et al.   ENVIRONMENTAL SCIENCE AND POLLUTION RESEARCH

Effects of perfluoroalkyl acids on the function of the thyroid hormone and the aryl hydrocarbon receptor

(2013) Manhai Long et al.   ENVIRONMENTAL SCIENCE AND POLLUTION RESEARCH

Gene–diet interactions on plasma lipid levels in the Inuit population

(2012) Iwona Rudkowska et al.   BRITISH JOURNAL OF NUTRITION

Tissue bioaccumulation patterns, xenobiotic biotransformation and steroid hormone levels in Atlantic salmon (Salmo salar) fed a diet containing perfluoroactane sulfonic or perfluorooctane carboxylic acids

(2011) Anne S. Mortensen et al.   CHEMOSPHERE

Soy Isoflavones, CYP1A1, CYP1B1, and COMT Polymorphisms, and Breast Cancer: A Case–Control Study in Southwestern China

(2011) Qiong Wang et al.   DNA AND CELL BIOLOGY

Perfluorinated compounds are related to breast cancer risk in greenlandic inuit: A case control study

(2011) Eva C Bonefeld-Jorgensen et al.   Environmental Health

Comparison ofin vitrocytotoxicity, estrogenicity and anti-estrogenicity of triclosan, perfluorooctane sulfonate and perfluorooctanoic acid

(2011) Natasha D. Henry et al.   JOURNAL OF APPLIED TOXICOLOGY

Combined effect ofCYP1B1,COMT,GSTP1, andMnSODgenotypes and risk of postmenopausal breast cancer

(2011) Jasmina-Ziva Cerne et al.   Journal of Gynecologic Oncology

COMT Val158Met polymorphism and breast cancer risk: evidence from 26 case–control studies

(2010) Haixia Ding et al.   BREAST CANCER RESEARCH AND TREATMENT

Association between CYP19 polymorphisms and breast cancer risk: results from 10,592 cases and 11,720 controls

(2010) Xiangyu Ma et al.   BREAST CANCER RESEARCH AND TREATMENT

Estrogen-Like Activity of Perfluoroalkyl Acids In Vivo and Interaction with Human and Rainbow Trout Estrogen Receptors In Vitro

(2010) Abby D. Benninghoff et al.   TOXICOLOGICAL SCIENCES

Genetic Polymorphism of Metabolic Enzymes P450 (CYP) as a Susceptibility Factor for Drug Response, Toxicity, and Cancer Risk

(2009) Nada Božina et al.   Arhiv za Higijenu Rada i Toksikologiju-Archives of Industrial Hygiene and Toxicology

Lack of association between catechol-O-methyltransferase Val108/158Met polymorphism and breast cancer risk: a meta-analysis of 25,627 cases and 34,222 controls

(2009) Chen Mao et al.   BREAST CANCER RESEARCH AND TREATMENT

Factors influencing the association between CYP17 T34C polymorphism and the risk of breast cancer: meta-regression and subgroup analysis

(2009) Yun Chen et al.   BREAST CANCER RESEARCH AND TREATMENT

No association between CYP17 T-34C polymorphism and breast cancer risk: a meta-analysis involving 58,814 subjects

(2009) Lei Yao et al.   BREAST CANCER RESEARCH AND TREATMENT

Four polymorphisms in cytochrome P450 1A1 (CYP1A1) gene and breast cancer risk: a meta-analysis

(2009) Theodoros N. Sergentanis et al.   BREAST CANCER RESEARCH AND TREATMENT

A high frequent BRCA1 founder mutation identified in the Greenlandic population

(2009) Theresa Larriba Harboe et al.   Familial Cancer

Association of genetic polymorphisms of ER-α and the estradiol-synthesizing enzyme genes CYP17 and CYP19 with breast cancer risk in Chinese women

(2008) Lina Zhang et al.   BREAST CANCER RESEARCH AND TREATMENT

Cancer patterns in Inuit populations

(2008) Jeppe T Friborg et al.   LANCET ONCOLOGY